Search results for "Type 2"

showing 10 items of 1034 documents

Family history of type 2 diabetes and altered maximal aerobic capacity in elite young athletes: a cross-sectional study.

2008

Aim. Family history of type 2 diabetes is a predictive risk factor of illness in sedentary subjects and induces early phenotypic and metabolic alterations. The aim of this study was to determine whether a family history of diabetes in young male athletes had an effect on metabolic functional parameters. Methods. The study population was 42 young male athletes with or without a family history of type 2 diabetes. Anthropometric parameters, body composition, and maximal aerobic capacity (V̇O2max) were assessed. Results. V̇O2max was lower in the 13 athletes with a family history of diabetes (FH+) than in the 29 athletes without a family history of the disorder (FH-) matched for kilogram of body…

family historyexercisediabetes mellitus type 2 geneticmaximum aerobic powerSettore BIO/09 - Fisiologia
researchProduct

Cell Therapy in Type 1 Diabetes

2011

The incidence of diabetes mellitus has grown exponentially in the last few years. Etiopathogenesis of diabetes implies a ?-cells damage in the islet of Langerhans, either through an autoimmune reaction present in type 1 diabetic patients or through altered function within these cells that affect their ability to secrete a properly functioning insulin hormone, in patients suffering from type 2 diabetes. Exogenous insulin supply is, at the moment, the therapy of choice of the disease but it does not allow tight control of glucose regulation, leading to long-term complications. Over the past few decades, pancreas or pancreas-kidney organ transplantation has been the most effective treatment fo…

geographyType 1 diabetesmedicine.medical_specialtygeography.geographical_feature_categorybusiness.industryInsulinmedicine.medical_treatmentType 2 diabetesIsletmedicine.diseaseBioinformaticsOrgan transplantationTransplantationDiabetes mellitusImmunologymedicinePancreatic islet transplantationbusinessJournal of Stem Cell Research & Therapy
researchProduct

Differences and Similarities in Neuropathy in Type 1 and 2 Diabetes: A Systematic Review

2021

Background: Diabetic neuropathy is defined as the dysfunction of the peripheral nervous system in diabetic patients. It is considered a microvascular complication of diabetes mellitus. Its presence is associated with increased morbidity and mortality. Although several studies have found alterations at somatic motor, sensory levels and at the level of autonomic nervous system in diabetic patients, there is not a systematic approach regarding the differences in neuropathy between the major variants of diabetes, e.g., type 1 and 2 diabetes at both neurological and molecular level. Data sources: we systematically (Medline, Scopus, and Cochrane databases) evaluated the literature related to the …

insulinmedicine.medical_specialtyDiabetic neuropathymusclemedicine.medical_treatmentlcsh:MedicineMedicine (miscellaneous)030209 endocrinology & metabolismReviewType 2 diabetesthermal sensitivityvibratory sensitivity03 medical and health sciences0302 clinical medicineInfermeriaInternal medicineDiabetes mellitusValsalva maneuverMedicine030212 general & internal medicineType 1 diabetesAdiponectinbusiness.industryInsulinlcsh:Rbiomarkersmedicine.diseasecytokinesAutonomic nervous systembusinessJournal of Personalized Medicine
researchProduct

Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index?

2011

Alice Engel1,2, Jana Helfrich1, Nina Manderscheid1, Petra B Musholt3, Thomas Forst3, Andreas Pfützner3, Norbert Dahmen1,21Department of Psychiatry, University of Mainz, Germany; 2Fachklinik Katzenelnbogen, Katzenelnbogen, Germany; 3IKFE, Institute for Clinical Research and Development, Mainz, GermanyBackground: Narcolepsy is a severe sleep-wake cycle disorder resulting in most cases from a lack of orexin, the energy balance-regulating hormone. Narcoleptic patients have been reported to suffer from an excess morbidity of Type 2 diabetes, even after correction for their often elevated body mass index.Methods: To explore whether narcolepsy is specifically associated with a propensity …

insulinobesitymedicine.medical_specialtyPathologyNeuropsychiatric Disease and Treatmentmedicine.medical_treatmentnarcolepsyNeurosciences. Biological psychiatry. NeuropsychiatryType 2 diabetesInsulin resistanceInternal medicinemedicineintact proinsulinRC346-429Biological PsychiatryOriginal ResearchProinsulinbusiness.industryInsulinmedicine.diseaseOrexinPsychiatry and Mental healthEndocrinologyHomeostatic model assessmentNeurology. Diseases of the nervous systemfasting glucosebusinessBody mass indexRC321-571NarcolepsyNeuropsychiatric Disease and Treatment
researchProduct

Metformīna intolerances patoģenēze

2019

Pētijuma mērķis: Identificēt, kādi faktori var ietekmēt uz metformīna intoleranci. Aktualitāte: Katru gadu pieaug pacientu skaits ar 2TCD un daudziem pacientim attistās intolerance no metformīna. Materiāli un metodes: Šis ir prospektīvi pētijums, kurā tika analizēti 384 II tipa cukura diabēta pacientu dati. 340 pacienti lietoja metformīnu, bet 42 nelietoja metforminu. 36 pacientiem, kuri lietoja metforminu bija blakusparādības, šī pacientu grupa bija pētāmā grupa, savukārt 304 pacienti, kuriem nebija blakusparādību no metformina lietošanas, tika iekļauti kontrolgrupā. Kontrolgrupā un pētāmā grupā tika analizēti un salīdzināti dažādi pacientu faktori, lai noteiktu to ietekmi uz blakusparādīb…

intolerance intoleranceMetformīns Metformin2 tipa cukura diabēts Type 2 diabetesinhibītori inhibitorsMedicīna
researchProduct

Leisure-time physical activity, weight gain and health : a prospective follow-up in twins

2011

keskivartalolihavuuskuolleisuusProspektiivinen tutkimusphysical activitymorbidityweighthealthKaksostutkimustwinsprospective follow-upliikuntawaist circumferencemortalitypainonnousukaksosetSeurantatutkimustype 2 diabeteskrooniset tauditchronic diseaseterveysliikuntaterveysaikuistyypin diabetesfyysinen aktiivisuusvapaa-aika
researchProduct

Aberrant brain functional networks in type 2 diabetes mellitus: A graph theoretical and support-vector machine approach

2022

ObjectiveType 2 diabetes mellitus (T2DM) is a high risk of cognitive decline and dementia, but the underlying mechanisms are not yet clearly understood. This study aimed to explore the functional connectivity (FC) and topological properties among whole brain networks and correlations with impaired cognition and distinguish T2DM from healthy controls (HC) to identify potential biomarkers for cognition abnormalities.MethodsA total of 80 T2DM and 55 well-matched HC were recruited in this study. Subjects’ clinical data, neuropsychological tests and resting-state functional magnetic resonance imaging data were acquired. Whole-brain network FC were mapped, the topological characteristics were ana…

kognitiiviset taidottype 2 diabetes mellitusmagneettikuvaushermoverkot (biologia)resting-state MRIbiomarkkeritBehavioral NeurosciencePsychiatry and Mental healthkoneoppiminenaivokuoriNeuropsychology and Physiological PsychologyNeurologyauditory cortexsupport vector machinetopological propertiesaikuistyypin diabetescognitive functionBiological PsychiatryFrontiers in Human Neuroscience
researchProduct

Perceived sufficiency of physical activity levels among adults at high risk of type 2 diabetes. The FIN-D2D study

2012

Purpose. This study assessed the determinants of perceived physical activity levels (PALs) among adults at high risk of diabetes, and the associations with self-reported physical activity. Methods. In total, 10,149 adults participated in the FIN-D2D lifestyle intervention at baseline. Opportunistic screening was used in identifying high risk individuals. Physical activity and perceived PAL sufficiency were assessed and compared. Key risk factors for diabetes and psychosocial and demographic characteristics were analyzed as determinants using logistic regression. Results. PAL sufficiency was rated realistically by 73% of men and 75% of women. Perception of sufficient PAL was more likely amon…

kokeminentietoisuustyypin 2 diabetesehkäisyphysical activitylifestyle interventionelintapainterventioperceptionhumanitiesFIN-D2Dawarenessennaltaehkäisytype 2 diabetesfyysinen aktiivisuusriittävyys
researchProduct

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diab…

2017

Aims These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent comorbidities in patients with T2D, accounting for 50% of mortality. Following recent CV outcomes trial (CVOT) results, including those from EMPA-REG OUTCOME®, LEADER®, SUSTAIN™-6 and, most recently, the CANVAS study, it is essential to develop regional expert consensus recommendations to aid physicians in interpreting these newest data to clinical practice. Methods The Central and Eastern European Diabetes Expert Group (CEEDEG) followed a Delphi method …

lcsh:Diseases of the circulatory (Cardiovascular) systemKeywords: Anti-glycaemic drugs ; Cardiovascular disease ; Renal disease ; Type 2 diabetesmedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDelphi method610 Medicine & health030209 endocrinology & metabolismReviewType 2 diabetesDisease030204 cardiovascular system & hematologyAnti-glycaemic drugs2705 Cardiology and Cardiovascular MedicineTranslational Research BiomedicalRenal disease03 medical and health sciences0302 clinical medicineMultidisciplinary approachDiabetes mellitusDiabetes MellitusmedicineHumansHypoglycemic AgentsEurope EasternIntensive care medicineExpert TestimonyClinical Trials as Topicbusiness.industryType 2 diabetesCardiovascular diseasemedicine.diseaseExpert groupEuropeEastern european2712 Endocrinology Diabetes and MetabolismTreatment Outcome2724 Internal MedicineCardiovascular Diseaseslcsh:RC666-701Practice Guidelines as TopicCardiology and Cardiovascular MedicinebusinessKidney diseaseCardiovascular Diabetology
researchProduct

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

2020

[This corrects the article DOI: 10.3389/fimmu.2019.01151.].

lcsh:Immunologic diseases. Allergycritical limb ischemiamedicine.medical_specialtyclinical trialsdiabetesbusiness.industrycost-effectivecell-based therapyImmunologyType 2 Diabetes MellitusCorrectionCritical limb ischemiamedicine.diseasecellular medicamentsCell therapyClinical trialDiabetes mellitusInternal medicinemedicineImmunology and Allergymedicine.symptombusinesslcsh:RC581-607
researchProduct